ImmunityBio (IBRX) EBIT Margin (2014 - 2026)
ImmunityBio (IBRX) reported EBIT Margin of 157.88% for Q1 2026, up 23220.0% year-over-year from N/an in Q1 2025, and up 6.55% quarter-over-quarter from 168.95% in Q4 2025.
ImmunityBio (IBRX) EBIT Margin (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of EBIT Margin data on file, last reported at 157.88% in Q1 2026.
- EBIT Margin for Q1 2026 came in at 157.88%, up 23220.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 185.41% (up 81841.0% YoY), and the FY2025 annual result was 226.0%, up 210823.0% from the prior year.
- EBIT Margin grew to 157.88% in Q1 2026 per IBRX's latest filing, from 168.95% in the prior quarter.
- Over five years, EBIT Margin peaked at 157.88% in Q1 2026 and troughed at 685514.29% in Q1 2022.
- A 5-year average of 103232.55% and a median of 30994.44% in 2023 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin slumped 62345385 bps in 2022, then soared 65451984 bps in 2023.
- A 5-year view of EBIT Margin shows it stood at 116301.37% in 2022, then soared by 47 bps to 61430.94% in 2023, then surged by 99 bps to 918.96% in 2024, then soared by 82 bps to 168.95% in 2025, then grew by 7 bps to 157.88% in 2026.
- Business Quant data shows IBRX's EBIT Margin at 157.88% in Q1 2026, 168.95% in Q4 2025, and 173.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | -157.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157.88% |
| Dec 31, 2025 | -168.95% |
| Sep 30, 2025 | -173.51% |
| Jun 30, 2025 | -269.76% |
| Mar 31, 2025 | -390.08% |
| Dec 31, 2024 | -918.96% |
| Sep 30, 2024 | -1,314.33% |
| Jun 30, 2024 | -9,487.39% |
| Mar 31, 2024 | -237,990.00% |
| Dec 31, 2023 | -61,430.94% |
| Sep 30, 2023 | -97,726.83% |
| Jun 30, 2023 | -207,670.73% |
| Mar 31, 2023 | -30,994.44% |
| Dec 31, 2022 | -116,301.37% |
| Sep 30, 2022 | -76,952.54% |
| Jun 30, 2022 | -227,491.43% |
| Mar 31, 2022 | -685,514.29% |
| Dec 31, 2021 | -20,326.67% |
| Sep 30, 2021 | -119,448.48% |
| Jun 30, 2021 | -25,341.00% |